Novartis to exit Indian unit in $159 million deal
Swiss drugmaker Novartis said on Friday it would sell its entire 70.68% stake in its listed Indian unit for 14.46 ...
Read moreTag: Novartis
Sanofi MS drug tolebrutinib misses goal in relapsing disease trials
Sanofi’s most advanced multiple sclerosis (MS) drug candidate has missed the main goal of two late-stage trials to treat relapsing ...
Read morePopular Post
FRSHAR Mail set to redefine secure communication, data privacy
How to avoid buyer’s remorse when raising venture capital
Microsoft to pay off cloud industry group to end EU antitrust complaint
Capacity utilisation of Pakistan’s cement industry drops to lowest on record
Inflation is down in Europe. But the European Central Bank is in no hurry to make more rate cuts
American Dollar Exchange Rate